These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15812931)

  • 21. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
    Myers T; Cockerill R; Millson M; Rankin J; Worthington C
    AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harm reduction policies in Argentina: a critical view.
    Epele ME; Pecheny M
    Glob Public Health; 2007; 2(4):342-58. PubMed ID: 19283632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure to MTV's global HIV prevention campaign in Kathmandu, Nepal; São Paulo, Brazil; and Dakar, Senegal.
    Geary CW; Burke HM; Castelnau L; Neupane S; Sall YB; Wong E
    AIDS Educ Prev; 2007 Feb; 19(1):36-50. PubMed ID: 17411388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harm reduction in Europe: a framework for civil society-led monitoring.
    Rigoni R; Tammi T; van der Gouwe D; Schatz E
    Harm Reduct J; 2021 Jan; 18(1):3. PubMed ID: 33407566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of community-based nurses in harm reduction for HIV prevention: a South East and South Asia case study.
    Limbu B
    Int J Drug Policy; 2008 Jun; 19(3):211-3. PubMed ID: 18440796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiological impact and cost-effectiveness of HIV testing, antiretroviral treatment and harm reduction programs.
    Li J; Gilmour S; Zhang H; Koyanagi A; Shibuya K
    AIDS; 2012 Oct; 26(16):2069-78. PubMed ID: 22781221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using the Venom of a Snake for an Antidote: exploring strategies and services for sex workers in preparation for the World Cup 2014.
    Ewen JE
    Perspect Public Health; 2015 Jul; 135(4):197-203. PubMed ID: 25228529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Building partnerships between law enforcement and harm reduction programs.
    Jardine M
    Int J Drug Policy; 2013 Sep; 24(5):377-8. PubMed ID: 23867048
    [No Abstract]   [Full Text] [Related]  

  • 29. Bangkok 2004. Youth: too often missing from the response.
    Fransen RF
    HIV AIDS Policy Law Rev; 2004 Dec; 9(3):80-3. PubMed ID: 15812927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From prohibition to harm reduction? An analysis of the adoption of the Dutch harm reduction approach in Brazilian drug laws and practice.
    Fonseca MD; van Wingerden SGC
    Int J Drug Policy; 2020 Sep; 83():102842. PubMed ID: 32652512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brazilian Public Policies on Drugs: An Analysis Considering the Aspects of Assistance, Prevention, and Supply Control.
    de Souza J; Fiorati RC; Macedo MM; de Macedo JQ
    J Addict Nurs; 2018; 29(1):50-56. PubMed ID: 29505461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug policy in Canada--the way forward.
    Kerr T; O'Briain W
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):1, 27-32. PubMed ID: 14765475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A public policy approach to local models of HIV/AIDS control in Brazil.
    Le Loup G; de Assis A; Costa-Couto MH; Thoenig JC; Fleury S; de Camargo K; Larouzé B
    Am J Public Health; 2009 Jun; 99(6):1108-15. PubMed ID: 19372523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug policies in the Brazilian context: an intersectional analysis of "Cracolândia" in São Paulo, Brazil].
    Marques ALM; Couto M
    Salud Colect; 2020 Jul; 16():e2517. PubMed ID: 33147388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of public support toward federal funding for harm reduction strategies.
    Kulesza M; Teachman BA; Werntz AJ; Gasser ML; Lindgren KP
    Subst Abuse Treat Prev Policy; 2015 Jun; 10():25. PubMed ID: 26122408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Civil society-a leader in HIV prevention and tobacco control.
    Malinowska-Sempruch K; Bonnell R; Hoover J
    Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of exposures to policing on syringe sharing among people who inject drugs in Bangkok, Thailand.
    Hayashi K; Ti L; Buxton JA; Kaplan K; Suwannawong P; Kerr T
    AIDS Behav; 2013 Oct; 17(8):2615-23. PubMed ID: 23797832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decolonizing harm reduction.
    Lasco G
    Harm Reduct J; 2022 Feb; 19(1):8. PubMed ID: 35114995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UN leadership and harm reduction: a rough road.
    Csete J
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):24-5. PubMed ID: 16365968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. State of the art science addressing injecting drug use, HIV and harm reduction.
    Beg M; Strathdee SA; Kazatchkine M
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S1-4. PubMed ID: 25727257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.